Articles

East meets West for MoU

BGI, Hummingbird Diagnostics join hands for early diagnosis of Alzheimer’s and Parkinson's diseases
Written byLori Lesko
| 3 min read

HEIDELBERG, Germany—Targeted toward the early detection of Alzheimer’s and Parkinson's diseases, Hummingbird Diagnostics GmbH of Heidelberg, Germany, and Shenzhen, China-based BGI have joined hands for a memorandum of understanding (MoU) aimed at establishing a broad collaboration of miRNA-based molecular diagnostic applications built on next-generation sequencing (NGS) technology. The actual agreement is expected to launch sometime in mid-2018.

A microRNA (miRNA) is a kind of short non-coding RNA—miRNAs play important roles in the regulation of molecular biological processes, and these nucleic acids may be used as biomarkers in the detection of disease.

The terms of the MoU, signed Dec. 6, 2017, call for the companies to jointly develop broad-spectrum targeted miRNA in-vitro diagnostic assays for Alzheimer’s and Parkinson’s diseases and other human pathologies based on Hummingbird’s expertise, sample preparation know-how, miRNA database and a pipeline using BGISEQ (BGI’s own NGS platform) with its advantages for miRNA sequencing. Furthermore, the companies agreed to cooperate in the field of wellness, fitness and aging-related questions in general.

To continue reading this article, subscribe for FREE toDrug Discovery News Logo

Subscribe today to keep up to date with the latest advancements and discoveries in drug development achieved by scientists in pharma, biotech, non-profit, academic, clinical, and government labs.

Add Drug Discovery News as a preferred source on Google

Add Drug Discovery News as a preferred Google source to see more of our trusted coverage.

About the Author

Here are some related topics that may interest you:

Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Gloved hand holding a multiwell cell culture plate under a fluorescence microscope for spheroid analysis.
Using confocal live-cell imaging to characterize immune-mediated cytotoxicity over time.
Fluorescence microscopy image of cells displaying green and red fluorescent signals.
Using confocal live-cell imaging to assess treatment effects in spheroids, organoids, and co-cultures.
3D illustration of Y-shaped antibody molecules floating against a soft blue background, with a detailed antibody structure in the foreground.
From molecular developability to functional activity, integrated characterization strategies help inform lead selection and optimization in biologics discovery.